Literature DB >> 24734507

Recent advances in the nanotechnology-based drug delivery of Silybin.

Yancai Wang, Ling Zhang, Qiwei Wang, Dianrui Zhang.   

Abstract

Silybin is the main component of silymarin and is a polyphenolic bioactive natural product found in the milk thistle plant Silybum marianum. Silybin possesses many health-promoting benefits, such as antioxidation and anticancer. However, the benefits are curtailed by its extremely poor water solubility. Consequently, the bioavailability and therapeutic effective of silybin is also limited. Nanotechnology is an available approach to solving these issues. Currently, nanosuspensions, micelles, nanoparticles, nano-emulsions, etc. are used to improve the in vitro dissolution velocity and in vivo efficiency of silybin. The present work reviews the nanotechnology-based applications and developments on silybin production. Silybin can also be utilized as a reference for the production and development of other water-insoluble drug delivery systems.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24734507     DOI: 10.1166/jbn.2014.1798

Source DB:  PubMed          Journal:  J Biomed Nanotechnol        ISSN: 1550-7033            Impact factor:   4.099


  7 in total

Review 1.  Targeting Glioblastoma with the Use of Phytocompounds and Nanoparticles.

Authors:  Francesca Pistollato; Susanne Bremer-Hoffmann; Giuseppe Basso; Sandra Sumalla Cano; Iñaki Elio; Manuel Masias Vergara; Francesca Giampieri; Maurizio Battino
Journal:  Target Oncol       Date:  2016-02       Impact factor: 4.493

Review 2.  Competitive glucose metabolism as a target to boost bladder cancer immunotherapy.

Authors:  Julieta Afonso; Lúcio L Santos; Adhemar Longatto-Filho; Fátima Baltazar
Journal:  Nat Rev Urol       Date:  2020-01-17       Impact factor: 14.432

Review 3.  Formulation Strategies for Enhancing the Bioavailability of Silymarin: The State of the Art.

Authors:  Alfonso Di Costanzo; Ruggero Angelico
Journal:  Molecules       Date:  2019-06-07       Impact factor: 4.411

Review 4.  Nanocarrier-mediated antioxidant delivery for liver diseases.

Authors:  Senlin Li; Huiru Li; Xiaoding Xu; Phei Er Saw; Lei Zhang
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

5.  Nanostructured lipid system as a strategy to improve the anti-Candida albicans activity of Astronium sp.

Authors:  Bruna Vidal Bonifácio; Matheus Aparecido dos Santos Ramos; Patrícia Bento da Silva; Kamila Maria Silveira Negri; Érica de Oliveira Lopes; Leonardo Perez de Souza; Wagner Vilegas; Fernando Rogério Pavan; Marlus Chorilli; Taís Maria Bauab
Journal:  Int J Nanomedicine       Date:  2015-08-10

Review 6.  Microfluidization trends in the development of nanodelivery systems and applications in chronic disease treatments.

Authors:  Palanivel Ganesan; Govindarajan Karthivashan; Shin Young Park; Joonsoo Kim; Dong-Kug Choi
Journal:  Int J Nanomedicine       Date:  2018-10-09

Review 7.  The Evaluation of Drug Delivery Nanocarrier Development and Pharmacological Briefing for Metabolic-Associated Fatty Liver Disease (MAFLD): An Update.

Authors:  Reem Abou Assi; Ibrahim M Abdulbaqi; Chan Siok Yee
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.